ArticleTheranostics2019

Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy.

Christopher B Rodell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.